East Bay biotech's different approach to cancer leads to $80 million IPO

The company is the 12th Bay Area life sciences company to file to go public in 2018.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.